BIO 2026 | Eric Lee | Boreal Biomanufacturing

Moving a therapeutic program from academic discovery to a scalable, patient-ready product is famously difficult.

In this live segment from BIO International Convention 2026 in San Diego, we sit down with Eric Lee, General Manager of Boreal Biomanufacturing, at the Ontario Canada pavilion. Eric shares the exciting story behind the organization’s recent rebrand from the Ottawa Hospital’s Biotherapeutics Manufacturing Centre (BMC), detailing how they are restructuring to act as a launchpad for advanced therapeutics.

Eric outlines how a specialized CDMO built within a world-class hospital ecosystem can provide a unique pipeline for oncology and complex rare disease innovators, ensuring life-saving ideas don't get trapped in the lab.